Cargando…
Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis
Glucagon-like Peptide-1 receptor agonists (GLP1-ra) are a relatively new class of anti-hyperglycemic drugs which may positively affect bone metabolism and thereby decrease (osteoporotic) bone fracture risk. Data on the effect of GLP1-ra on fracture risk are scarce and limited to clinical trial data...
Autores principales: | Driessen, Johanna H. M., Henry, Ronald M. A., van Onzenoort, Hein A. W., Lalmohamed, Arief, Burden, Andrea M., Prieto-Alhambra, Daniel, Neef, Cees, Leufkens, Hubert G. M., de Vries, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491344/ https://www.ncbi.nlm.nih.gov/pubmed/25894068 http://dx.doi.org/10.1007/s00223-015-9993-5 |
Ejemplares similares
-
Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs
por: Driessen, Johanna H. M., et al.
Publicado: (2015) -
Knee Arthroplasty and Risk of Hip Fracture: A Population-Based, Case–Control Study
por: Lalmohamed, Arief, et al.
Publicado: (2011) -
Thiazolidinediones and Glucagon‐Like Peptide‐1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study
por: van Dalem, Judith, et al.
Publicado: (2021) -
Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study
por: Wvan der Zanden, Rogier, et al.
Publicado: (2015) -
Patterns of Risk of Cancer in Patients with Metal-on-Metal Hip Replacements versus Other Bearing Surface Types: A Record Linkage Study between a Prospective Joint Registry and General Practice Electronic Health Records in England
por: Lalmohamed, Arief, et al.
Publicado: (2013)